Menu
Search
Home
Data Trends
World
Americas
Europe
Asia-Pacific
MEA
Opinion
The editor
The global lawyer
Regional perspectives
Free Zone Focus
FDI analysis
News
Features
Interviews
Videos
Partner Content
Rankings & awards
European Cities and Regions of the Future
Global Free Zones of the Year
Greenfield FDI Performance index
Special reports
Magazine
Products & Services
Products & Services
fDi Markets
fDi Benchmark
fDi Insights
InvestmentFlow
IncentivesFlow
InvestmentMap
fDi Influencers
fDi Intelligence
ZoomProspector
ZoomTour
fDi Strategies
Events and Roundtable
Advertising Opportunities
Training Workshops
Amplify
fDi Institute
Contact Us
Supply chains
576 results
Pharmaceuticals
Eli Lilly’s $9bn US expansion shows soaring appetite for weight loss drugs
Investment promotion
Can IPAs help firms navigate ESG ‘tsunami’?
Editorial
China shifts to capital exports
Global
Opinion | Investment screening: remaining open but safe
News
Greece ranked most complex country to do business in
Advertisement
Ukraine war
Russian outward FDI goes sanctions-jumping into non-OECD countries
News
Global greenfield FDI continues nuanced recovery in 2023
Law
Opinion | EU’s forced labour ban is global benchmark
News
Xi's trip to Europe followed China’s FDI trail
View from Asia-Pacific
Opinion | Asean: the world’s tier-2 powerhouse
Advertisement
Previous
9
Next